Skip to main content

Market Overview

Why Neovasc's Stock Is Trading Lower Today


Neovasc (NASDAQ: NVCN) shares are trading lower after the company announced a $72 million registered direct offering priced at-the-market.

Neovasc Inc is a specialty medical device company. The company develops, manufactures and markets products for the rapidly growing cardiovascular marketplace.

Its products include the Tiara for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina. Neovasc is developing the Tiara for the treatment of mitral valve disease.

Neovasc stock was down 21.83% at $1.79. The stock has a 52-week high of $3.88 and a 52-week low of 68 cents.


Related Articles (NVCN)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at